INOGEN, INC. (INGN) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
51/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseINGN / S&P 4.37% / 15.20% |
LoseINGN / S&P 5.09% / 15.00% |
LoseINGN / S&P -14.15% / 50.40% |
| 2026-Q10/3 |
LoseINGN / S&P -8.04% / -4.33% |
LoseINGN / S&P 5.32% / 11.30% |
LoseINGN / S&P -20.00% / 27.70% |
| 2025-Q40/3 |
LoseINGN / S&P -17.75% / 2.65% |
LoseINGN / S&P 5.94% / 9.00% |
LoseINGN / S&P -42.76% / 13.40% |
| 2025-Q32/3 |
WinINGN / S&P 16.22% / 8.12% |
WinINGN / S&P 7.79% / 4.61% |
LoseINGN / S&P -55.11% / 13.45% |
| 2025-Q21/3 |
LoseINGN / S&P -1.40% / 10.94% |
WinINGN / S&P 9.05% / 4.83% |
LoseINGN / S&P -73.30% / 10.63% |
| 2025-Q11/3 |
LoseINGN / S&P -22.25% / -4.27% |
WinINGN / S&P 9.78% / 4.98% |
LoseINGN / S&P -72.29% / 10.57% |
| 2024-Q41/3 |
LoseINGN / S&P -5.46% / 2.41% |
WinINGN / S&P 10.79% / 5.25% |
LoseINGN / S&P -65.53% / 6.15% |
| 2024-Q31/3 |
WinINGN / S&P 19.31% / 5.89% |
LoseINGN / S&P 2.44% / 5.89% |
LoseINGN / S&P -60.87% / 6.11% |
| 2024-Q20/3 |
LoseINGN / S&P 0.74% / 4.28% |
LoseINGN / S&P -8.05% / 5.38% |
LoseINGN / S&P -5.48% / 5.12% |
| 2024-Q12/3 |
WinINGN / S&P 46.99% / 10.56% |
LoseINGN / S&P -16.25% / 5.71% |
WinINGN / S&P 5.60% / 5.59% |
| 2023-Q41/3 |
LoseINGN / S&P 5.17% / 11.69% |
LoseINGN / S&P -21.51% / 6.81% |
WinINGN / S&P 20.16% / 7.78% |
| 2023-Q31/3 |
LoseINGN / S&P -54.81% / -3.27% |
LoseINGN / S&P -14.59% / 7.52% |
WinINGN / S&P 161.36% / -5.03% |
| 2023-Q21/3 |
LoseINGN / S&P -7.45% / 8.74% |
LoseINGN / S&P -4.30% / 9.50% |
WinINGN / S&P 236.00% / -8.57% |
| 2023-Q11/3 |
LoseINGN / S&P -36.68% / 7.50% |
LoseINGN / S&P 2.31% / 10.77% |
WinINGN / S&P 346.59% / -15.69% |
| 2022-Q41/3 |
LoseINGN / S&P -18.82% / 7.56% |
LoseINGN / S&P 2.83% / 11.88% |
WinINGN / S&P 1165.52% / -17.99% |
| 2022-Q31/3 |
WinINGN / S&P 0.41% / -4.88% |
LoseINGN / S&P -0.72% / 13.47% |
LoseINGN / S&P -558.33% / -1.41% |
| 2022-Q21/3 |
LoseINGN / S&P -25.42% / -16.10% |
LoseINGN / S&P 0.74% / 13.71% |
WinINGN / S&P 861.54% / 11.04% |
| 2022-Q11/3 |
LoseINGN / S&P -4.65% / -4.60% |
LoseINGN / S&P 10.19% / 15.97% |
WinINGN / S&P 282.61% / 42.23% |
| 2021-Q40/3 |
LoseINGN / S&P -21.10% / 11.03% |
LoseINGN / S&P 11.26% / 15.00% |
LoseINGN / S&P 7.41% / 96.40% |
| 2021-Q30/3 |
LoseINGN / S&P -33.88% / 0.58% |
LoseINGN / S&P 8.29% / 10.77% |
LoseINGN / S&P -633.33% / 69.42% |
| 2021-Q21/3 |
WinINGN / S&P 24.09% / 8.55% |
LoseINGN / S&P -3.17% / 6.58% |
LoseINGN / S&P -143.33% / 51.81% |
| 2021-Q11/3 |
WinINGN / S&P 17.55% / 6.17% |
LoseINGN / S&P -19.10% / -1.06% |
LoseINGN / S&P -136.51% / 7.39% |
| 2020-Q41/3 |
WinINGN / S&P 54.07% / 12.15% |
LoseINGN / S&P -17.72% / -3.72% |
LoseINGN / S&P -128.72% / -33.42% |
| 2020-Q30/3 |
LoseINGN / S&P -18.36% / 8.93% |
LoseINGN / S&P -16.90% / -2.04% |
LoseINGN / S&P -106.25% / -27.10% |
| 2020-Q20/3 |
LoseINGN / S&P -31.24% / 20.54% |
LoseINGN / S&P -12.11% / -0.46% |
LoseINGN / S&P -83.87% / -27.11% |
| 2020-Q10/3 |
LoseINGN / S&P -24.40% / -19.60% |
LoseINGN / S&P -2.41% / 3.47% |
LoseINGN / S&P -69.42% / -14.75% |
| 2019-Q41/3 |
WinINGN / S&P 42.62% / 9.07% |
LoseINGN / S&P 1.35% / 5.36% |
LoseINGN / S&P -59.13% / 2.99% |
| 2019-Q31/3 |
LoseINGN / S&P -28.24% / 1.70% |
WinINGN / S&P 10.90% / 5.02% |
LoseINGN / S&P -21.31% / 0.21% |
| 2019-Q22/3 |
LoseINGN / S&P -30.00% / 4.30% |
WinINGN / S&P 22.32% / 6.64% |
WinINGN / S&P 30.07% / 8.65% |
| 2019-Q12/3 |
LoseINGN / S&P -23.19% / 13.65% |
WinINGN / S&P 37.19% / 8.12% |
WinINGN / S&P 77.59% / 14.29% |
| 2018-Q42/3 |
LoseINGN / S&P -49.14% / -13.52% |
WinINGN / S&P 49.01% / 9.05% |
WinINGN / S&P 142.11% / 18.23% |
| 2018-Q33/3 |
WinINGN / S&P 31.01% / 7.71% |
WinINGN / S&P 49.53% / 10.21% |
WinINGN / S&P 50.00% / 19.06% |
| 2018-Q23/3 |
WinINGN / S&P 51.69% / 3.43% |
WinINGN / S&P 48.13% / 9.03% |
WinINGN / S&P 25.44% / 14.46% |
| 2018-Q12/3 |
WinINGN / S&P 3.16% / -0.76% |
WinINGN / S&P 39.59% / 7.68% |
LoseINGN / S&P 3.57% / 12.46% |
| 2017-Q42/3 |
WinINGN / S&P 25.22% / 6.64% |
WinINGN / S&P 34.09% / 7.03% |
LoseINGN / S&P -2.06% / 13.82% |
| 2017-Q32/3 |
LoseINGN / S&P -0.34% / 4.48% |
WinINGN / S&P 35.75% / 5.68% |
WinINGN / S&P 32.61% / 17.57% |
| 2017-Q23/3 |
WinINGN / S&P 23.03% / 3.09% |
WinINGN / S&P 41.88% / 4.83% |
WinINGN / S&P 42.50% / 17.74% |
| 2017-Q13/3 |
WinINGN / S&P 15.47% / 6.07% |
WinINGN / S&P 46.96% / 3.67% |
WinINGN / S&P 83.61% / 13.32% |
| 2016-Q43/3 |
WinINGN / S&P 12.14% / 3.82% |
WinINGN / S&P 48.00% / 2.09% |
WinINGN / S&P 70.18% / 7.05% |
| 2016-Q33/3 |
WinINGN / S&P 19.54% / 3.85% |
WinINGN / S&P 49.96% / 0.20% |
WinINGN / S&P 100.00% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | INGN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -31.04% | 20.78% |
| Annualized return | -31.04% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | INGN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -90.90% | 83.14% |
| Annualized return | -38.09% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | INGN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -90.49% | 319.30% |
| Annualized return | -20.97% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B |